Literature DB >> 24060996

Absolute proteomic quantification of the activity state of proteases and proteolytic cleavages using proteolytic signature peptides and isobaric tags.

Richard P Fahlman1, Wei Chen1, Christopher M Overall2.   

Abstract

Proteolytic processing alters the structure and function of a wide range of proteins in the proteome. We describe a method for the absolute quantification of proteolysis that is compatible with existing quantitative proteomic applications and could be applied on a protein-family wide scale. A tryptic peptide spanning a cleavage site differentiates this intact form of the protein from the corresponding semi-tryptic peptides of a protease cleaved protein. We term such proteomic signatures of specific proteolytic events "proteolytic signature peptides" (PSPs). By quantifying both the tryptic and semi-tryptic PSPs simultaneously with proteotypic peptides common to all forms of the protein both the relative and the absolute amounts of the intact and cleaved protein can be determined. Using synthetic PSP standards of cleavage sites in intact and cleaved proteins the absolute amounts of each form of the protein can be determined. The technique was demonstrated by the simultaneous identification and quantification of matrix metalloproteinase zymogens and their proteolytically activated forms in parallel with conventional absolute quantification of their TIMP inhibitors. For quantification we synthesized a pair of isobaric mass tags, we term CLIP-TRAQ, using C(13) labeled reagents that when fragmented during CID generate signature ions at 113.1 or 114.1 respectively. As an expandable platform this allows for the simultaneous identification of multiple proteins and their proteolytic state in complex proteomes on a family-wide scale in parallel with conventional proteomic analysis. This article is part of a Special Issue entitled: CNPN 2013. BIOLOGICAL SIGNIFICANCE: Proteolysis is key to various biological processes and the activity and function of many proteins are dictated by their proteolytic state. The development of methods to quantify protein abundance in conjunction to determining their proteolytic state and hence activity is essential for the complete understanding of the processes for which proteolysis is involved. This article is part of a Special Issue: Can Proteomics Fill the Gap Between Genomics and Phenotypes?
© 2013.

Entities:  

Keywords:  Degradomics; MMPs; Protease; Proteolytic cleavages; Proteomics; iTRAQ synthesis

Mesh:

Substances:

Year:  2013        PMID: 24060996     DOI: 10.1016/j.jprot.2013.09.006

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  9 in total

1.  Functional roles of MMP14 and MMP15 in early postnatal mammary gland development.

Authors:  Tamar Y Feinberg; R Grant Rowe; Thomas L Saunders; Stephen J Weiss
Journal:  Development       Date:  2016-09-15       Impact factor: 6.868

2.  Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1: a meaningful and independent marker to predict stroke in the Chinese population.

Authors:  Wen-Jun Tu; Xiao-Ye Liu; Hao Dong; Yan Yu; Yi Wang; Hui Chen
Journal:  J Mol Neurosci       Date:  2013-12-19       Impact factor: 3.444

3.  A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity.

Authors:  David J Marchant; Caroline L Bellac; Theo J Moraes; Samuel J Wadsworth; Antoine Dufour; Georgina S Butler; Leanne M Bilawchuk; Reid G Hendry; A Gordon Robertson; Caroline T Cheung; Julie Ng; Lisa Ang; Zongshu Luo; Karl Heilbron; Michael J Norris; Wenming Duan; Taylor Bucyk; Andrei Karpov; Laurent Devel; Dimitris Georgiadis; Richard G Hegele; Honglin Luo; David J Granville; Vincent Dive; Bruce M McManus; Christopher M Overall
Journal:  Nat Med       Date:  2014-04-28       Impact factor: 53.440

4.  State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project.

Authors:  Terry Farrah; Eric W Deutsch; Gilbert S Omenn; Zhi Sun; Julian D Watts; Tadashi Yamamoto; David Shteynberg; Micheleen M Harris; Robert L Moritz
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

Review 5.  Mass spectrometry-based methods for identifying oxidized proteins in disease: advances and challenges.

Authors:  Ivan Verrastro; Sabah Pasha; Karina Tveen Jensen; Andrew R Pitt; Corinne M Spickett
Journal:  Biomolecules       Date:  2015-04-14

Review 6.  New beginnings and new ends: methods for large-scale characterization of protein termini and their use in plant biology.

Authors:  Andreas Perrar; Nico Dissmeyer; Pitter F Huesgen
Journal:  J Exp Bot       Date:  2019-04-12       Impact factor: 6.992

7.  The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies.

Authors:  C H Borchers; J Kast; L J Foster; K W M Siu; C M Overall; T A Binkowski; W H Hildebrand; A Scherer; M Mansoor; P A Keown
Journal:  J Proteomics       Date:  2013-08-08       Impact factor: 4.044

Review 8.  Current strategies and findings in clinically relevant post-translational modification-specific proteomics.

Authors:  Oliver Pagel; Stefan Loroch; Albert Sickmann; René P Zahedi
Journal:  Expert Rev Proteomics       Date:  2015-05-08       Impact factor: 3.940

9.  Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.

Authors:  Qingbin Li; Baoshi Chen; Jinquan Cai; Ying Sun; Guangzhi Wang; Yongli Li; Ruiyan Li; Yan Feng; Bo Han; Jianlong Li; Yu Tian; Liye Yi; Chuanlu Jiang
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.